Incarda Therapeutics
Closed
39899 Balentine Dr Ste 185
Newark, CA 94560
InCarda Therapeutics is a biopharmaceutical company based in Newark, CA, specializing in a transformative approach to cardiovascular disease. With a focus on atrial fibrillation, their pipeline includes orally inhaled flecainide, offering a novel treatment option for patients.
Driven by a dedicated team of experts and supported by a strong board of directors and investors, InCarda Therapeutics is committed to advancing innovative solutions that address the unmet needs of patients with cardiovascular conditions.
Generated from the website
Also at this address
See a problem?
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.